FindTrial
Sign In

To evaluate pain amelioration effect of Platelet Rich Plasma in patients of trigeminal neuralgia and assessment of VAS score, sleep adequacy, satisfaction with treatment

Evaluation of pain amelioration effect of Platelet Rich Plasma in Trigeminal Neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051703
Enrollment
25
Registered
2023-04-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G500- Trigeminal neuralgia

Interventions

Intervention1: Injection of Platelet rich plasma in patients of Trigeminal Neuralgia .10 ml blood will be withdrawn and PRP prepared by running it through centrifuge machine . First soft spin for 10 m

Sponsors

Pt. B D Sharma University of Health Sciences, PGIMS Rohtak Haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade I and II Chronic pain of Trigeminal Neuralgia (T1,T2,T3) for atleast 3 months VAS score >5 without satisfactory pain relief from standard treatment

Exclusion criteria

Exclusion criteria: Unwillingness to participate History of previous local anaesthetic infilteration Metastasis Fever Diabetes Bleeding disorder/ on antiplatelet or anticoagulants drugs Viral marker positive patients Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Visual Analogue ScaleTimepoint: 2weeks , 4weeks, 8weeks , 12weeks after procedure—

Secondary

MeasureTime frame
Patient satisfactionTimepoint: 2weeks , 4weeks, 8weeks , 12weeks after procedure;Quality of SleepTimepoint: 2weeks , 4weeks, 8weeks , 12weeks after procedure—

Countries

India

Contacts

Public ContactDr Devyani Verma

Pt. B D Sharma PGIMS Rohtak

dvdevyaniverma@gmail.com9467179040

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026